Health
Reducing COVID-19 burden with monoclonal antibodies and vaccination – News-Medical.Net
Researchers in the United States, the UK and France have shown that using antiviral monoclonal antibodies in combination with vaccination can be expected to suppress…
Researchers in the United States, the UK and France have shown that using antiviral monoclonal antibodies in combination with vaccination can be expected to suppress the transmission of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) and reduce the burden of coronavirus disease 2019 (COVID-19) more than vaccination alone.
The team’s modeling simulations suggested that the near-term use of monoclonal antibodies (mAbs) for early treatment and post-exposure prophylaxis (PEP) in combination…
Continue Reading
